Literature DB >> 22837940

Does Vitamin D therapy affect hematological indices in adolescents with vitamin D deficiency?

Ashraf T Soliman1, Muhamed Eldabbagh, Ahmed Elawwa, Wael Saleem.   

Abstract

Entities:  

Year:  2012        PMID: 22837940      PMCID: PMC3401780          DOI: 10.4103/2230-8210.98038

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


× No keyword cloud information.
Sir, Analysis of the nonclassic actions of vitamin D (3) has highlighted a wide range of target tissues for the hormone 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)]. Vitamin D is a steroid hormone that can act on the cellular differentiation and growth in the bone marrow either directly or through hyperparathyroidism. Both systemic or locally produced 1,25 (OH)(2)D(3) may play a role in modulating cell development processes such as hematopoiesis and lymphocyte differentiation.[1-3] Thus vitamin D deficiency (VDD) may have an adverse effect on the red blood cell (RBC) erythropoiesis in the bone marrow and partially explain the high incidence of iron-deficiency anemia and recurrent infections in children with VDD. Vitamin D insufficiency has also been linked to hypertension and cardiovascular events in observational studies. It is unclear whether vitamin D supplementation can reduce blood pressure.[4] Children with higher BP levels at about 9 years of age and with large increases in BP from 9 to 18 years of age may have an increased risk of becoming hypertensive.[5] We examined the effect of vitamin D3 therapy (10,000 IU/ kg, IM) on RBC count and indices and total and differential white blood cell (WBC) counts as well as on the blood pressure BP) and heart rate (HR) in 40 adolescents (age =14.6 ± 2.5 years) with VDD (blood level < 15 ng/ml) before after 4 weeks of therapy (vitamin D replete state). There was no significant effect of VDD on RBC count or indices before versus after correction of vitamin D status. Vitamin D therapy did not have any significant effect on total WBC count nor on the lymphocyte/neutrophil ratio. We detected small but significant increases in the platelet and monocyte counts after vitamin D therapy (P < 0.04 and 0.03 respectively). There was no significant effect of VDD on BP or HR and correction of VDD did not significantly change the BP or HR. No significant correlation was detected between RBC indices, WBC count, and BP on the one hand and vitamin D level on the other hand [Table 1].
Table 1

Hematological data before versus after vitamin D therapy

Hematological data before versus after vitamin D therapy Vitamin D deficiency does not have significant effect on RBC count and indices, on WBC total and differential count, nor on BP and HR. A mega-dose vitamin D therapy did not have significant effect on all these parameters in adolescents.
  5 in total

1.  Myeloid metaplasia in vitamin D deficiency rickets.

Authors:  S Yetgin; S Ozsoylu
Journal:  Scand J Haematol       Date:  1982-02

2.  Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3.

Authors:  T Bellido; G Girasole; G Passeri; X P Yu; H Mocharla; R L Jilka; A Notides; S C Manolagas
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

Review 3.  Effect of vitamin D on blood pressure: a systematic review and meta-analysis.

Authors:  Miles D Witham; M Adnan Nadir; Allan D Struthers
Journal:  J Hypertens       Date:  2009-10       Impact factor: 4.844

4.  Blood pressure changes during adolescence and subsequent adult blood pressure level.

Authors:  B Woynarowska; D Mukherjee; A F Roche; R M Siervogel
Journal:  Hypertension       Date:  1985 Sep-Oct       Impact factor: 10.190

5.  The effect of vitamin D3 on CD34 progenitor cells in vitamin D deficiency rickets.

Authors:  Sevgi Yetgin; S Songül Yalçin
Journal:  Turk J Pediatr       Date:  2004 Apr-Jun       Impact factor: 0.552

  5 in total
  1 in total

1.  Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients.

Authors:  Dina Sabry; Mohamed As Al-Ghussein; Gehan Hamdy; Amr Abul-Fotouh; Tarek Motawi; Amany Y El Kazaz; Ahmed Eldemery; Marwa Shaker
Journal:  Ther Clin Risk Manag       Date:  2015-02-19       Impact factor: 2.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.